Skip to content

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

News

Select Year
Clinical Trials
Search …

August 3, 2011

Oncolytics Biotech® Inc. to Present at 31st Canaccord Genuity Growth Conference

August 2, 2011

Oncolytics Biotech® Inc. Announces Publication of Preclinical Research on Synergistic Combination of Chemotherapy with Oncolytic Virotherapy

July 28, 2011

Oncolytics Biotech® Inc. Announces Second Quarter 2011 Results

July 6, 2011

Oncolytics Biotech® Inc. Collaborators Present Positive REOLYSIN® Clinical Trial Results at the 14th World Conference on Lung Cancer

July 5, 2011

Oncolytics Biotech Announces Appointment of Dr. George M. Gill as Chief Medical Officer

June 8, 2011

Oncolytics Biotech® Inc. Collaborators to Present Reovirus Research at the 14th World Conference on Lung Cancer

June 2, 2011

MEDIA ADVISORY – Oncolytics Biotech® Inc. to Present at Jeffries 2011 Global Healthcare Conference

May 12, 2011

Oncolytics Biotech® Inc. Announces First Quarter 2011 Results

May 12, 2011

Oncolytics Biotech® Inc. Reports Correction to First Quarter 2011 Results Press Release

May 11, 2011

Oncolytics Biotech® Inc. Enters into Commercial Supply Agreement with SAFC®

Page 51 of 71

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Loading...

4350 Executive Drive
Suite 325
San Diego, CA 92121
info@oncolyticsbiotech.com

Company

Our Mission
Leadership
Board of Directors
Careers
Contact

Science

Our Science
Pipeline
Resources

Investors

Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs

Privacy Policy Accessibility Cookie Policy Disclaimer Manage Consent

Copyright © 2026 Oncolytics Biotech Inc.